HROW

HARROW, INC.

Healthcare · Drug Manufacturers - Specialty & Generic

$46.97 sample

+0.17 (+0.36%) 1D

Market cap

$201.3B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-17

Alerts

8

Price$46.97 +3.53% 3M daily closessample

50.9645.00

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 05INSInsider sell: 10% owner
Sep 25INSInsider sell: Chief Executive Officer
Sep 17SEC10-Q filed
Sep 10INSInsider sell: 10% owner
Sep 01SEC10-Q filed
Aug 21INSInsider sell: EVP, Operations
Aug 17SEC10-Q filed
Aug 07INSInsider sell: Chief Financial Officer

Sign up to see the real HROW record →

Company facts

SEC EDGAR registration

Name: HARROW, INC.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Smart-money score: -55sample, -100 to +100
Reporting currency: USD

Who is positioning in HROW

sample

Insiders: 16 insider transactions over 90 days, net selling, $879.1M
Congress: No member trades over 90 days
Institutions · 13F: 12 funds hold $3.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$12.1B +23.2% y/y

Q4 2024Q3 2026

Inventory$7.1B +13.9% y/y

Q4 2024Q3 2026

Accounts receivable$5.1B +10.2% y/y

Q4 2024Q3 2026

Total debt$13.8B +15.4% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $195.7B -1.8% 3M
Sample peer B: $22.3B +3.3% 3M
Sample peer C: $161.8B -9.4% 3M
Sample peer D: $149.7B +11.2% 3M
Sample peer E: $118.6B +16.3% 3M